MedPath

The effect of scaling and root planning treatment on serum level of IL 23 and IL35 in patients with periodontitis and type 2 diabetes mellitus

Not Applicable
Recruiting
Conditions
Condition 1: Type 2 diabetes mellitus. Condition 2: chronic periodontitis.
Type 2 diabetes mellitus
Chronic periodontitis
Registration Number
IRCT20171108037325N2
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

patient with type 2 diabetes mellitus and periodontitis

Exclusion Criteria

Patients with advanced renal liver and heart failure
Patients treated with drugs that increase insulin resistance and increase blood glucose include prednisolone, cyclosporine, and others.
Patients who have been taking antibiotics for the last three months or have recieved periodontal treatment
Patients with fewer than 14 teeth
Pregnant patients
Smokers
Hemorrhagic diseases
Patients with uncontrolled diabetes mellitus (8.5 <HBA1C) who need to increase their dose of oral medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IL23. Timepoint: before intervention/3 months after intervention. Method of measurement: Unit Pg / ml, using Eliza Reader.;IL35. Timepoint: before intervention/3 months after intervention. Method of measurement: Unit Pg / ml, using Eliza Reader.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath